Abderaouf Hamza

6PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersMolecular targetsMedical biotechnology diagnostics (incl. biosensors)Cardiovascular medicine and haematology not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Sep 10, 2025
Molecular analysis of lung adenocarcinomas from the SAFIR02-Lung cohort reveals new metastasis-associated copy-number alterations including frequent mutant-specific KRAS-allelic imbalance and identifies CDKN2A homozygous deletions as an independent biomarker of poor prognosis.

Abderaouf Hamza, Pierre Gestraud, Maryam Karimi

|Jun 12, 2025
Genomic landscape of estrogen receptor-positive HER2-negative advanced breast cancer with acquired resistance to aromatase inhibitors: Identification of an ESR1 alteration-related gene signature.

Solenn Barraud, Sophie Vacher, Camille Schiffler

|Aug 28, 2024
Genomic analysis of adult thrombotic microangiopathies in less than 3 days: from rapid to fast genomics to treatment.

Nadhir Yousfi, Cyril Mousseaux, Abderaouf Hamza

|Apr 24, 2024
EZH2 mutations in follicular lymphoma distort H3K27me3 profiles and alter transcriptional responses to PRC2 inhibition.

Pierre Romero, Laia Richart, Setareh Aflaki

|Nov 01, 2023
Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.

Abderaouf Hamza, Julien Masliah-Planchon, Cindy Neuzillet

|Apr 09, 2023
The absence of CFHR3 and CFHR1 genes from the T2T-CHM13 assembly can limit the molecular diagnosis of complement-related diseases.

Abderaouf Hamza, Carine El-Sissy, Nadhir Yousfi

Pageof 1

Frequent Collaborators

2 joint publications

Laurent Mesnard

2 joint publications

Ivan Bièche

2 joint publications

Fabrice André

2 joint publications

Marta Jimenez